CastleKnight Management’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.14M Hold
65,300
0.03% 224
2025
Q1
$821K Buy
+65,300
New +$821K 0.03% 181